The invention provides human engineered antibodies, antigen-binding fragments thereof, that bind to, and inhibit the activity of, human DKK-1, and which are effective in treating diseases in which pathogenesis is mediated by DKK-1.
申请公布号
UA103916(C2)
申请公布日期
2013.12.10
申请号
UA20110011272
申请日期
2010.04.06
申请人
ELI LILLI AND COMPANY
发明人
CHEDID, MARCIO;DARLING, RYAN, JAMES;GALVEN, RACHELLE, JEANETTE;SWANSON, BARBARA, ANNE
